Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections

FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections

USPTO allows Isis an additional patent for single-stranded RNAi technology

USPTO allows Isis an additional patent for single-stranded RNAi technology

Ascent Therapeutics demonstrates Pepducin efficacy

Ascent Therapeutics demonstrates Pepducin efficacy

Esperance Pharmaceuticals begins human clinical trials of its EP-100 cancer therapeutic candidate

Esperance Pharmaceuticals begins human clinical trials of its EP-100 cancer therapeutic candidate

Aperio Technologies forges alliance with HistoRx to provide an integrated whole-slide imaging system

Aperio Technologies forges alliance with HistoRx to provide an integrated whole-slide imaging system

ADDF's grant to Abiant for developing accurate imaging diagnostic approach

ADDF's grant to Abiant for developing accurate imaging diagnostic approach

BioLeap and GSK collaborate to discover novel medicines

BioLeap and GSK collaborate to discover novel medicines

Applications invited from scientists for LBD Biomarker Research Award

Applications invited from scientists for LBD Biomarker Research Award

Proteostasis Therapeutics to use GeneGo's MetaCore integrated software

Proteostasis Therapeutics to use GeneGo's MetaCore integrated software

Zinc finger nucleases utilized for modifying hESCs and hiPSCs

Zinc finger nucleases utilized for modifying hESCs and hiPSCs

Newly established McClay Foundation to encourage healthcare research in Northern Ireland

Newly established McClay Foundation to encourage healthcare research in Northern Ireland

Small molecule inhibitors could create new combination therapies

Small molecule inhibitors could create new combination therapies

StrataTest to be launched in the European market

StrataTest to be launched in the European market

Optimized turmeric extracts may prevent memory loss

Optimized turmeric extracts may prevent memory loss

Ten of ChemBridge's screening libraries available through CDD database

Ten of ChemBridge's screening libraries available through CDD database

Celgene to collaborate with PTC on advancing drug discovery efforts

Celgene to collaborate with PTC on advancing drug discovery efforts

Innovative way for culturing liver cells improves drug toxicity screening

Innovative way for culturing liver cells improves drug toxicity screening

Analytical Technologies division of MDS to be acquired by Danaher

Analytical Technologies division of MDS to be acquired by Danaher

Patents for treatment for obesity acquired by Madrona Ventures, to start clinical trials soon

Patents for treatment for obesity acquired by Madrona Ventures, to start clinical trials soon

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.